Success Metrics

Clinical Success Rate
83.7%

Based on 41 completed trials

Completion Rate
84%(41/49)
Active Trials
5(7%)
Results Posted
34%(14 trials)
Terminated
8(11%)

Phase Distribution

Ph phase_3
28
37%
Ph phase_1
2
3%
Ph not_applicable
6
8%
Ph phase_4
28
37%
Ph phase_2
7
9%

Phase Distribution

2

Early Stage

7

Mid Stage

56

Late Stage

Phase Distribution71 total trials
Phase 1Safety & dosage
2(2.8%)
Phase 2Efficacy & side effects
7(9.9%)
Phase 3Large-scale testing
28(39.4%)
Phase 4Post-market surveillance
28(39.4%)
N/ANon-phased studies
6(8.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.9%

41 of 54 finished

Non-Completion Rate

24.1%

13 ended early

Currently Active

5

trials recruiting

Total Trials

75

all time

Status Distribution
Active(6)
Completed(41)
Terminated(13)
Other(15)

Detailed Status

Completed41
unknown15
Terminated8
Withdrawn5
Recruiting4
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
75
Active
5
Success Rate
83.7%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (2.8%)
Phase 27 (9.9%)
Phase 328 (39.4%)
Phase 428 (39.4%)
N/A6 (8.5%)

Trials by Status

withdrawn57%
not_yet_recruiting11%
active_not_recruiting11%
recruiting45%
completed4155%
terminated811%
unknown1520%

Recent Activity

Clinical Trials (75)

Showing 20 of 75 trialsScroll for more
NCT03817957Phase 3

Postoperative i.v. Iron Substitution in Patients With Diagnosed Iron Deficiency

Completed
NCT05309499Not Applicable

An Open Study on the Efficacy of Iron Therapy Using iv Iron Relative to Oral Iron for Increasing LV Systolic Function

Completed
NCT02632760Phase 4

Intravenous Iron for Treatment of Anaemia Before Cardiac Surgery

Completed
NCT04744181

Patient Blood Management In CARdiac sUrgical patientS

Completed
NCT07057973Not Applicable

The Effectiveness of Preoperative Iron Therapy in Improving Anemia After Multi-level Lumbar Fusion in the Elderly

Recruiting
NCT07053475Phase 4

IRONICA: IRON Repletion In Heart Failure - A Comparison of Oral and IV Approaches

Recruiting
NCT03833336Phase 3

Effects of Iron Therapy in Heart Failure With Preserved Ejection Fraction and Iron Deficiency (PREFER-HF)

Completed
NCT05545527

Neuroimaging Ancillary Study

Completed
NCT04625530Phase 3

Perioperative Management in Gynaecological Carcinoma Surgery

Withdrawn
NCT06080893Phase 4

The Effect of Preoperative Ferric Carboxymaltose Administration on Mortality in Geriatric Hip Fractures

Completed
NCT06437080Not Applicable

Hypoferritinemia Without Anemia Among Reproductive Age Females

Active Not Recruiting
NCT03680456Phase 4

Postoperative Replacement of Intraoperative Iron Losses

Completed
NCT05744219Phase 3

Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial

Recruiting
NCT04087993Phase 3

Polyglucoferron Compared to i.v. Ferric Carboxymaltose and Oral Iron Substitution in Preoperative Treatment of Iron Deficiency Anaemia in Patients

Withdrawn
NCT03769441Phase 3

Effect of Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation

Completed
NCT03037931Phase 3

Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study

Completed
NCT05358509Phase 4

Reducing Anemia in Pregnancy in India: the RAPIDIRON Trial

Completed
NCT04653181Not Applicable

Preoperative i.v. Iron Substitution in Patients With Colon Cancer

Recruiting
NCT03991000Phase 3

Iron in Patients With Cardiovascular Disease

Terminated
NCT05504863

RAPIDIRON Trial Follow-up Study: RAPIDIRON-KIDS Study

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
75